A trial to assess an extra-fine, inhaled formulation of beclomethasone/formoterol in patients with asthma switched from treatment with fluticasone/salmetrol or budesonide/formoterol

Trial Profile

A trial to assess an extra-fine, inhaled formulation of beclomethasone/formoterol in patients with asthma switched from treatment with fluticasone/salmetrol or budesonide/formoterol

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Sep 2014

At a glance

  • Drugs Beclometasone/formoterol (Primary)
  • Indications Asthma
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top